Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Date:3/19/2008

NEW YORK, March 19 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)

Drop

GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)

Add

Fornix Biosciences N.V. (Amsterdam: FORBI.AS)

Meda AB (SHSE1: MEDA A)

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)

Drop

Shire PLC (Nasdaq: SHPGY)

Add

Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)

Drop

Biosphere Medical, Inc. (Nasdaq: BSMD)

Add

Zoll Medical Corp. (Nasdaq: KERX)

Add

Dyanvax Technologies (Nasdaq: DVAX)

Synta Pharmaceuticals Corp. (Nasdaq: SNTA)

Enabling Technologies Index (HHV)

Drop

Hillenbrand Industries (NYSE: HB)

Add

Eurand N.V. (Nasdaq: EURX)

GI/Gender Index (HHU)

Drop

AEterna Zentaris (Nasdaq: AEZS)

King Pharmaceuticals (NYSE: KG)

Nastech Pharmaceutical (Nasdaq: NSTK)

Add

Columbia Laboratories Inc. (Nasdaq: CBRX)

Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)

Mylan, Inc. (NYSE: MYL)

Metabolic-Endocrine Disorders Index (HHM)

Drop

Depomed Inc. (Nasdaq: DEPO)

Emisphere Technologies Inc. (Nasdaq: EMIS)

Flamel Technologies SA ADS (Nasdaq: FLML)

Hospira Inc. (NYSE: HSP)

Human Genome Sciences, Inc. (Nasdaq: HGSI)

Indevus Pharmaceuticals Inc. (Nasdaq: IDEV)

Ipsen Ltd. (Paris: IPN.PR)

Nastech Pharmaceutical Co. (Nasdaq: NSTK)

Nektar Therapeutics (Nasdaq: NKTR)

NicOx S.A. (Paris: NCOX)

OSI Pharmaceuticals Inc. (Nasdaq: OSIP)

ProStrakan Group Plc (LSE: PSK.L)

Solvay S.A. (Brussels: SVYSY)

Add

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

Amicus Therapeutics, Inc. (Nasdaq: FOLD)

Biodel Inc. (Nasdaq: BIOD)

CombinatoRx Inc. (Nasdaq: CRXX)

GW Pharmaceuticals Plc (LSE: GWP.L)

Incyte Corp. (Nasdaq: INCY)

Orexigen Therapeutics, Inc. (Nasdaq: OREX)

Repros Therapeutics Inc. (Nasdaq: RPRX)

Sangamo BioSciences Inc. (Nasdaq: SGMO)

Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT)

SuperGen Inc. (Nasdaq: SUPG)

Transition Therapeutics Inc. (Nasdaq: TTHI)

XOMA Ltd. (Nasdaq: XOMA)

Neuroscience Index (HHN)

Drop

Neurochem Inc. (Nasdaq: NRMX)

Add

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Ophthalmology Index (HHZ)

Drop

Insite Vision Inc. (Amex: ISV)

Add

King Pharmaceuticals (NYSE: KG)

Patient Care Services Index (HHB)

Drop

Fresenius Medical Care (XETRA: FME.DE)

Add

Coventry Health Care Inc. (NYSE: CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at http://www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com

Ticker=ZOLL" onClick="var s=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ZOLL)

Cardiology Index (HRD)

Drop

Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY)

Human Genome Sciences, Inc (Nasdaq: HGSI)

Vical, Inc (Nasdaq: VICL)

Add

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Sangamo BioSciences Inc (Nasdaq: SGMO)

Sciele Pharma, Inc. (Nasdaq: SCRX)

Composite Index (HHQ)

Drop

Advanced Medical Optics, Inc. (NYSE: EYE)

Align Technology Inc. (Nasdaq: ALGN)

Array Biopharma Inc. (Nasdaq: ARRY)

ArthroCare Corp. (Nasdaq: ARTC)

Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP)

Fresenius Medical Care AG (XETRA: FME.DE)

GEDEON RICHTER RT (XETRA: R1G1.DE)

GENMAB A/S (Copenhagen: GEN.CO)

H. LUNDBECK A/S (Copenhagen: LUN.CO)

Human Genome Sciences (Nasdaq: HGSI)

Imclone Systems (Nasdaq: IMCL)

Inverness Medical Innovations (Amex: IMA)

Invitrogen Corp. (Nasdaq: IVGN)

Medarex Inc. (Nasdaq: MEDX)

Medicis Pharmaceutical (NYSE: MRX)

Mentor Corp. (NYSE: MNT)

ONYX Pharmaceuticals Inc. (Nasdaq: ONXX)

PDL BioPharma, Inc. (Nasdaq: PDLI)

Pharmion Corp. (Nasdaq: PHRM)

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX)

Regeneron Pharmaceuticals (Nasdaq: REGN)

Respironics Inc. (Nasdaq: RESP)

Sepracor Inc. (Nasdaq: SEPR)

Theravance Inc. (Nasdaq: THRX)

United Therapeutics Corp. (Nasdaq: UTHR)

Valeant Pharmaceuticals Int'l (NYSE: VRX)

Vertex Pharmaceuticals (Nasdaq: VRTX)

Add

Adolor Corp. (Nasdaq: ADLR)

ALLOS THERAPEUTICS INC. (Nasdaq: ALTH)

Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY)

Alpharma Inc. (NYSE: ALO)

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG)

ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI)

Ark Therapeutics (LSE: AKT.L)

Bavarian Nordic A/S (Copenhagen: BAVA.CO)

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Cardiome Pharma Corp. (Nasdaq: CRME)

Coventry Health Care Inc. (NYSE: CVH)

CRUCELL-ADR (Nasdaq: CRXL)

CUBIST PHARMACEUTICALS INC. (Nasdaq: CBST)

Discovery Laboratories Inc. (Nasdaq: DSCO)

Eisai Co. Ltd. (TSE: 4523.T)

Encysive Pharmaceuticals Inc. (Nasdaq: ENCY)

Enzo Biochem Inc. (NYSE: ENZ)

ENZON PHARMACEUTICALS INC. (Nasdaq: ENZN)

Exelixis Inc. (Nasdaq: EXEL)

Flamel Technologies (Nasdaq: FLML)

Illumina Inc. (Nasdaq: ILMN)

Incyte Corporation (Nasdaq: INCY)

Integra LifeSciences Holdings (Nasdaq: IART)

Meda AB (Stockholm: MEDAA.ST)

Mitsubishi Tanabe Pharma (TSE: 4508.T)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T)

Dermatology and Wound Index (HRW)

Drop

Shire PLC (ADR) (Nasdaq: SHPGY)

SkyePharma Plc (LSE: SKP.LN)

Add

Standard Chemical & Pharm. Co., Ltd. (TSE: 1720)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535)

Diagnostics Index (HHD)

Drop

CR Bard, Inc. (NYSE: BCR)

IDEXX Laboratories (Nasdaq: IDXX)

Add

Bruker Corporation (Nasdaq: BRKR)

Halozyme Therapeutic (Nasdaq: HALO)

Emerging Cancer Index (HHJ)

Drop

Adventrx Pharmaceuticals, Inc. (Amex: ANX)

Keryx Biopharmaceuticals, Inc. (Nasdaq:

SOURCE QED International Associates Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PRA International Announces New Office Opening in Mumbai
2. Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations
3. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
4. International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark
5. Chindex International, Inc. Announces Three-For-Two Stock Split
6. Resources Top 400,000 in Hopkins International Information Service
7. Egyptian foot care center recieves International Diabetes Federation grant
8. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
9. Position Statement Regarding Lt. Gov. Paterson from Tara A. Cortes, Ph.D, RN President and CEO of Lighthouse International
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
11. Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... for excellence in radiology marketing programs at the annual Building Better Radiology Marketing ... Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out in ...
(Date:2/24/2017)... Emeryville, CA (PRWEB) , ... February 24, 2017 ... ... Esparza for qualifying into the Senior International Elite division on February 12th. ... All Around divisions at the elite qualifier competition held in Las Vegas, Nevada. ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The 89th ... the winner of the 2016 National Education Policy Center Bunkum Award. We invite you ... in 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... and Strategies - 2016" report to their offering. ... The latest research Oesophageal ... data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and their ...
(Date:2/23/2017)... CITY, Calif. , Feb. 23, 2017 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that it will release fourth ... on Thursday, March 2nd, 2017. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:2/23/2017)... 2017 Obese people are seldom ... varicose veins in their body. The rising number of ... adoption of endovenous laser therapy for treatment of varicose ... therapy market, published by Future Market Insights, indicates ... consequences of obesity have collectively factored the growth in ...
Breaking Medicine Technology: